NASDAQ:CASM - CAS Medical Systems Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$2.06 +0.04 (+1.98 %)
(As of 06/22/2018 04:00 PM ET)
Previous Close$2.06
Today's Range$1.98 - $2.06
52-Week Range$0.59 - $2.06
Volume195,283 shs
Average Volume204,713 shs
Market Capitalization$57.99 million
P/E Ratio-7.63
Dividend YieldN/A
CAS Medical Systems logoCAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations. The company also offers repair services for parts. It markets products through its own sales force, distributors, and manufacturers' representatives, as well as through hospitals, surgery centers, and outpatient facilities. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.

Receive CASM News and Ratings via Email

Sign-up to receive the latest news and ratings for CASM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments


Debt-to-Equity Ratio-0.34
Current Ratio1.54
Quick Ratio1.38


Trailing P/E Ratio-7.63
Forward P/E Ratio-7.92
P/E GrowthN/A

Sales & Book Value

Annual Sales$18.76 million
Price / Sales3.15
Cash FlowN/A
Price / CashN/A
Book Value($0.40) per share
Price / Book-5.15


EPS (Most Recent Fiscal Year)($0.27)
Net Income$-2,330,000.00
Net Margins-9.72%
Return on EquityN/A
Return on Assets-40.08%


Outstanding Shares28,710,000

The Truth About Cryptocurrencies

CAS Medical Systems (NASDAQ:CASM) Frequently Asked Questions

What is CAS Medical Systems' stock symbol?

CAS Medical Systems trades on the NASDAQ under the ticker symbol "CASM."

How were CAS Medical Systems' earnings last quarter?

CAS Medical Systems Inc (NASDAQ:CASM) released its quarterly earnings results on Thursday, May, 10th. The medical technology company reported ($0.07) earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of ($0.08) by $0.01. The medical technology company earned $5.44 million during the quarter, compared to the consensus estimate of $4.85 million. View CAS Medical Systems' Earnings History.

When is CAS Medical Systems' next earnings date?

CAS Medical Systems is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for CAS Medical Systems.

Who are some of CAS Medical Systems' key competitors?

Who are CAS Medical Systems' key executives?

CAS Medical Systems' management team includes the folowing people:
  • Mr. Thomas M. Patton J.D., Chief Exec. Officer, Pres and Director (Age 54)
  • Mr. Jeffery A. Baird, Chief Financial Officer and Sec. (Age 64)
  • Mr. John K. Gamelin Ph.D., VP of R&D (Age 53)
  • Dr. Paul B. Benni Ph.D., Chief Scientific Officer (Age 50)
  • Susan Carron, Director of Corp. Communications

Has CAS Medical Systems been receiving favorable news coverage?

Media stories about CASM stock have been trending somewhat positive recently, Accern Sentiment reports. The research group identifies negative and positive media coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CAS Medical Systems earned a news sentiment score of 0.01 on Accern's scale. They also assigned press coverage about the medical technology company an impact score of 46.76 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

Who are CAS Medical Systems' major shareholders?

CAS Medical Systems' stock is owned by a number of of institutional and retail investors. Top institutional investors include Acuta Capital Partners LLC (18.17%). Company insiders that own CAS Medical Systems stock include James E Flynn and John Gamelin. View Institutional Ownership Trends for CAS Medical Systems.

Which institutional investors are buying CAS Medical Systems stock?

CASM stock was purchased by a variety of institutional investors in the last quarter, including Acuta Capital Partners LLC. View Insider Buying and Selling for CAS Medical Systems.

How do I buy shares of CAS Medical Systems?

Shares of CASM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CAS Medical Systems' stock price today?

One share of CASM stock can currently be purchased for approximately $2.06.

How big of a company is CAS Medical Systems?

CAS Medical Systems has a market capitalization of $57.99 million and generates $18.76 million in revenue each year. The medical technology company earns $-2,330,000.00 in net income (profit) each year or ($0.27) on an earnings per share basis. CAS Medical Systems employs 76 workers across the globe.

How can I contact CAS Medical Systems?

CAS Medical Systems' mailing address is 44 East Industrial Road, Branford CT, 06405. The medical technology company can be reached via phone at 203-488-6056 or via email at [email protected]

MarketBeat Community Rating for CAS Medical Systems (CASM)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  77 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  146
MarketBeat's community ratings are surveys of what our community members think about CAS Medical Systems and other stocks. Vote "Outperform" if you believe CASM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CASM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/23/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.